237 related articles for article (PubMed ID: 34082425)
1. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review.
Klimek L; Berger WE; Bousquet J; Keith PK; Smith P; Sole D; Scadding G; Kuhl HC; Nguyen DT; Kopietz F; Koltun A
Int Arch Allergy Immunol; 2021; 182(11):1026-1035. PubMed ID: 34082425
[TBL] [Abstract][Full Text] [Related]
2. Intranasal spray medications for maintenance therapy of allergic rhinitis.
Berger WE; Meltzer EO
Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
[TBL] [Abstract][Full Text] [Related]
3. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.
Scadding G; Price D; El-Shanawany T; Ahmed S; Ray J; Sargur R; Kumar N
BMJ Open; 2017 Apr; 7(4):e014777. PubMed ID: 28442578
[TBL] [Abstract][Full Text] [Related]
4. MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children.
Berger W; Bousquet J; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Wahn U
Allergy; 2016 Aug; 71(8):1219-22. PubMed ID: 27043452
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
Ilyina NI; Edin AS; Astafieva NG; Lopatin AS; Sidorenko IV; Ukhanova OP; Khanova FM
Int Arch Allergy Immunol; 2019; 178(3):255-263. PubMed ID: 30677766
[TBL] [Abstract][Full Text] [Related]
6. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark.
Haahr PA; Jacobsen C; Christensen ME
Int Forum Allergy Rhinol; 2019 Apr; 9(4):388-395. PubMed ID: 30659752
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and safety of MP-AzeFlu for the treatment of allergic rhinitis: a meta-analysis.
Zhong Z; Xun Y; Shi X; Guan B; Wang M
Eur Arch Otorhinolaryngol; 2022 May; 279(5):2457-2464. PubMed ID: 34415405
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu.
Klimek L; Demoly P; Price D
Expert Rev Clin Pharmacol; 2016; 9(5):705-14. PubMed ID: 26839083
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment.
Berger W; Meltzer EO; Amar N; Fox AT; Just J; Muraro A; Nieto A; Valovirta E; Wickman M; Bousquet J
Pediatr Allergy Immunol; 2016 Mar; 27(2):126-33. PubMed ID: 26928753
[TBL] [Abstract][Full Text] [Related]
10. Intranasal Azelastine and Fluticasone as Combination Therapy for Allergic Rhinitis: Systematic Review and Meta-analysis.
Debbaneh PM; Bareiss AK; Wise SK; McCoul ED
Otolaryngol Head Neck Surg; 2019 Sep; 161(3):412-418. PubMed ID: 30961435
[TBL] [Abstract][Full Text] [Related]
11. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Romania.
Agache I; Doros IC; Leru PM; Bucur I; Poenaru M; Sarafoleanu C
Rhinology; 2018 Mar; 56(1):33-41. PubMed ID: 28942457
[TBL] [Abstract][Full Text] [Related]
12. Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber.
Bousquet J; Meltzer EO; Couroux P; Koltun A; Kopietz F; Munzel U; Kuhl HC; Nguyen DT; Salapatek AM; Price D
J Allergy Clin Immunol Pract; 2018; 6(5):1726-1732.e6. PubMed ID: 29425904
[TBL] [Abstract][Full Text] [Related]
13. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.
Kaulsay R; Nguyen DT; Kuhl HC
Immun Inflamm Dis; 2018 Dec; 6(4):456-464. PubMed ID: 30306729
[TBL] [Abstract][Full Text] [Related]
14. Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study.
Klimek L; Price D; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; van Weissenbruch R; Pohl W; Kuhl HC; Scadding G; Mullol J
Int Arch Allergy Immunol; 2020; 181(10):754-764. PubMed ID: 32829329
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of Health Care Resource Utilization and Costs for Patients with Allergic Rhinitis on Single-Product or Free-Combination Therapy of Intranasal Steroids and Intranasal Antihistamines.
Harrow B; Sedaghat AR; Caldwell-Tarr A; Dufour R
J Manag Care Spec Pharm; 2016 Dec; 22(12):1426-1436. PubMed ID: 27882840
[TBL] [Abstract][Full Text] [Related]
16. A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.
Zhou B; Cheng L; Pan J; Wang H; Jin Y; Zhao C; Lin P; Tan G; Fang H; Zhang H; Zhou H; Dong Y; Kuhl HC; Ramalingam RK; Nguyen DT
Pulm Ther; 2023 Sep; 9(3):411-427. PubMed ID: 37580498
[TBL] [Abstract][Full Text] [Related]
17. A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US.
Prenner BM
J Asthma Allergy; 2016; 9():135-43. PubMed ID: 27468241
[TBL] [Abstract][Full Text] [Related]
18. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
Meltzer EO; LaForce C; Ratner P; Price D; Ginsberg D; Carr W
Allergy Asthma Proc; 2012; 33(4):324-32. PubMed ID: 22856633
[TBL] [Abstract][Full Text] [Related]
19. New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis.
Wolthers OD
Recent Pat Inflamm Allergy Drug Discov; 2013 Sep; 7(3):223-8. PubMed ID: 23862774
[TBL] [Abstract][Full Text] [Related]
20. Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis.
Klimek L; Mullol J; Hellings P; Gevaert P; Mösges R; Fokkens W
Expert Opin Pharmacother; 2016; 17(5):657-69. PubMed ID: 26800187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
